Pharmacielo Stock Performance
| PCLOF Stock | USD 0.06 0 4.69% |
The company holds a Beta of 0.42, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Pharmacielo's returns are expected to increase less than the market. However, during the bear market, the loss of holding Pharmacielo is expected to be smaller as well. Pharmacielo right now holds a risk of 13.11%. Please check Pharmacielo potential upside, day median price, and the relationship between the sortino ratio and skewness , to decide if Pharmacielo will be following its historical price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Pharmacielo has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Pharmacielo is not utilizing all of its potentials. The newest stock price disturbance, may contribute to mid-run losses for the stockholders. ...more
| Begin Period Cash Flow | 8.9 M | |
| Total Cashflows From Investing Activities | -1.7 M |
Pharmacielo |
Pharmacielo Relative Risk vs. Return Landscape
If you would invest 10.00 in Pharmacielo on August 26, 2024 and sell it today you would lose (3.90) from holding Pharmacielo or give up 39.0% of portfolio value over 90 days. Pharmacielo is currently producing 0.0345% returns and takes up 13.1141% volatility of returns over 90 trading days. Put another way, most equities are less risky on the basis of their return distribution than Pharmacielo, and majority of traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Pharmacielo Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmacielo's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Pharmacielo, and traders can use it to determine the average amount a Pharmacielo's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0026
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PCLOF |
Estimated Market Risk
| 13.11 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Pharmacielo is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Pharmacielo by adding Pharmacielo to a well-diversified portfolio.
Pharmacielo Fundamentals Growth
Pharmacielo Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Pharmacielo, and Pharmacielo fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Pharmacielo Pink Sheet performance.
| Return On Equity | -0.98 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (3.22) % | |||
| Current Valuation | 38.68 M | |||
| Shares Outstanding | 151.41 M | |||
| Price To Book | 4.28 X | |||
| Price To Sales | 7.25 X | |||
| Revenue | 1.94 M | |||
| EBITDA | (24.75 M) | |||
| Cash And Equivalents | 1.17 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 7.14 M | |||
| Debt To Equity | 0.70 % | |||
| Book Value Per Share | 0.06 X | |||
| Cash Flow From Operations | (20.07 M) | |||
| Earnings Per Share | (0.12) X | |||
| Total Asset | 35.96 M | |||
About Pharmacielo Performance
By analyzing Pharmacielo's fundamental ratios, stakeholders can gain valuable insights into Pharmacielo's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Pharmacielo has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Pharmacielo has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
PharmaCielo Ltd., together with its subsidiary, cultivates, processes, produces, and supplies medicinal-grade cannabis extracts, tetrahydrocannabinol, and related products. It serves health and wellness product manufacturers, pharmacies, medical clinics, and cosmetic companies in Canada and Colombia. Pharmacielo is traded on OTC Exchange in the United States.Things to note about Pharmacielo performance evaluation
Checking the ongoing alerts about Pharmacielo for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Pharmacielo help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Pharmacielo had very high historical volatility over the last 90 days | |
| Pharmacielo has some characteristics of a very speculative penny stock | |
| Pharmacielo has high likelihood to experience some financial distress in the next 2 years | |
| Pharmacielo has accumulated 7.14 M in total debt with debt to equity ratio (D/E) of 0.71, which is about average as compared to similar companies. Pharmacielo has a current ratio of 0.79, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Pharmacielo until it has trouble settling it off, either with new capital or with free cash flow. So, Pharmacielo's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pharmacielo sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pharmacielo to invest in growth at high rates of return. When we think about Pharmacielo's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 1.94 M. Net Loss for the year was (26.63 M) with loss before overhead, payroll, taxes, and interest of (4.17 M). | |
| Pharmacielo has accumulated about 1.17 M in cash with (20.07 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
- Analyzing Pharmacielo's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Pharmacielo's stock is overvalued or undervalued compared to its peers.
- Examining Pharmacielo's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Pharmacielo's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Pharmacielo's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Pharmacielo's pink sheet. These opinions can provide insight into Pharmacielo's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Pharmacielo Pink Sheet analysis
When running Pharmacielo's price analysis, check to measure Pharmacielo's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharmacielo is operating at the current time. Most of Pharmacielo's value examination focuses on studying past and present price action to predict the probability of Pharmacielo's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharmacielo's price. Additionally, you may evaluate how the addition of Pharmacielo to your portfolios can decrease your overall portfolio volatility.
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |